KP372-1(PDK1/Akt/Flt Dual Inhibitor)

≥98%

  • Product Code: 66611
  CAS:    331253-86-2
Molecular Weight: 224.182 g./mol Molecular Formula: C₁₀H₄N₆O
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20℃
Product Description: KP372-1 is primarily utilized in cancer research due to its ability to inhibit key signaling pathways involved in tumor growth and survival. It targets PDK1, Akt, and Flt, which are critical components of cellular processes like proliferation, metabolism, and apoptosis. By blocking these pathways, KP372-1 effectively suppresses the survival of cancer cells, making it a promising candidate for studying novel therapeutic strategies. Its application is particularly relevant in investigating drug resistance mechanisms and developing targeted treatments for cancers that rely on these signaling networks, such as certain types of leukemia and solid tumors. Additionally, it serves as a valuable tool in preclinical studies to understand the molecular basis of cancer progression and to evaluate the efficacy of combination therapies.
Product Specification:
Test Specification
APPEARANCE Conform
PURITY 98-100
Infrared spectrum Conforms to Structure
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days $618.05
+
-
KP372-1(PDK1/Akt/Flt Dual Inhibitor)
KP372-1 is primarily utilized in cancer research due to its ability to inhibit key signaling pathways involved in tumor growth and survival. It targets PDK1, Akt, and Flt, which are critical components of cellular processes like proliferation, metabolism, and apoptosis. By blocking these pathways, KP372-1 effectively suppresses the survival of cancer cells, making it a promising candidate for studying novel therapeutic strategies. Its application is particularly relevant in investigating drug resistance mechanisms and developing targeted treatments for cancers that rely on these signaling networks, such as certain types of leukemia and solid tumors. Additionally, it serves as a valuable tool in preclinical studies to understand the molecular basis of cancer progression and to evaluate the efficacy of combination therapies.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: $0.00
$0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page